US Patent Issued to SAOL INTERNATIONAL DEVELOPMENT, UNIVERSITY OF FLORIDA RESEARCH FOUNDATION on Oct. 20 for "Method for monitoring and preventing clinically significant ketone levels in patients receiving dichloroacetate co-administered with a carbohydrate restricted diet" (American, Irish Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,768,840, issued on Oct. 20, was assigned to SAOL INTERNATIONAL DEVELOPMENT LTD. (Hamilton, Bermuda) and UNIVERSITY OF FLORIDA RESEARCH FOUNDATION Inc. (Fla.).

"Method for monitoring and preventing clinically significant ketone levels in patients receiving dichloroacetate co-administered with a carbohydrate restricted diet" was invented by David Penake (Atlanta), Susan Clement (Zionsville, Pa.), John Devane (Dublin), Sharon Hamm (Odessa, Fla.), Peter Stacpoole (Gainesville, Fla.) and Richard Wagner (Bloomington, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of controlling unhealthy levels of beta-hydroxybutyrate during dichloroacetate admin...